Pharma facilities often face delayed commercial manufacturing and missed market entry due to gaps in integrated test planning, CQV misalignment, and poor resource coordination. Launches stall, revenue is lost and reputation suffers when robust protocols, cross-functional coordination and milestone-driven validation are not rigorously managed from the outset.